Gala GLP-1 Semaglutide Review

Gala GLP-1 is a telehealth platform that combines GLP-1 weight loss with hormone replacement therapy (HRT), positioning itself for people—particularly women in midlife and menopause—who want to address weight and hormones together. Our investigation found a transparent, direct-pay model with an unusual dual focus.

Weight Loss and Hormones Together

Beyond GLP-1 medications, Gala offers estradiol, progesterone, and other hormone therapies for menopause symptoms. For midlife patients whose weight challenges intersect with hormonal changes, having both managed on one platform is a genuine differentiator.

Medication Options

• Compounded GLP-1/GIP (tirzepatide): $179/month
• Microdosing GLP-1/GIP (tirzepatide): $149/month—a lower-dose option
• Ozempic® (brand semaglutide): $1,299/month
• Wegovy® pill: Noted as coming soon

The compounded options are the value play; the brand-name Ozempic price reflects typical cash-pay cost without insurance.

How It Works

Gala is fully telehealth-based with licensed providers available in all 50 states. Initial consultations may be video or messaging-based depending on state laws and medication type, and members get 24/7 chat support with providers for dosage adjustments and questions. No insurance is required—pricing is transparent and direct.

Important: Compounded Medications

Gala notes plainly that compounded GLP-1 is not FDA-approved and is sourced from licensed compounding pharmacies. Compounded medications have not been evaluated by the FDA for safety, effectiveness, or quality, and members should understand this.

What We'd Watch

Gala is a very new platform—its footer lists "AI Coaching, Inc." and a 2026 copyright—so it has little public track record, and company details are limited. The compounded GLP-1 options are tirzepatide-based, with brand-name semaglutide (Ozempic) priced at full cash rates. For midlife patients who want weight loss and hormone care together, though, it's a focused option.